Status:
RECRUITING
Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Rectum Cancer
Stoma Colostomy
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Colorectal cancer is one of the most common cancers. However, approaches to minimize surgical trauma, preserve anal function, avoid abdominal stoma, and improve quality of life for patients...
Eligibility Criteria
Inclusion
- Histological proof of newly diagnosed primary adenocarcinoma of the rectum
- The lower edge of tumor \< 3 cm from the dentate line
- Clinical T stage ≤ T3
Exclusion
- The lower edge of tumor \< 1 cm from the dentate line
- Locally advanced stage of tumor
- Presence of metastatic disease or recurrent rectal tumor
- Concomitant malignancies
- Concurrent uncontrolled medical conditions
- Impaired anal function before surgery
- Presence of acute bowel obstruction or bowel perforation caused by cancer
- Pregnancy or breast feeding
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05245565
Start Date
May 1 2021
End Date
May 1 2026
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, 200072